Summary
In a significant market movement during February 2023, Evonetix was the subject of a vc funding. The transaction achieved a gross valuation of £20,038,430. Leading the round was Molten Ventures, Providence Ventures, Cambridge Consultants, Morningside, Civilization Ventures, DCVC, Foresite Capital.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Molten Ventures
Lead Investor / Acquirer
Providence Ventures
Lead Investor / Acquirer
Cambridge Consultants
Lead Investor / Acquirer
Morningside
Lead Investor / Acquirer
Civilization Ventures
Lead Investor / Acquirer
DCVC
Lead Investor / Acquirer
Foresite Capital
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series B prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in